ABCL
USDAbCellera Biologics Inc. Common Shares
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$3.200
Максимум
$3.310
Минимум
$3.080
Объем
8.00M
Фундаментальные показатели компании
Рыночная капитализация
940.2M
Отрасль
Биотехнология
Страна
Canada
Статистические данные торговли
Средний объем
4.49M
Биржа
NMS
Валюта
USD
52-недельный диапазон
Связанные новости
Truist Securities Maintains Buy on AbCellera Biologics, Lowers Price Target to $10
Truist Securities analyst Robyn Karnauskas maintains AbCellera Biologics with a Buy and lowers the price target from $28 to $10.
AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause
AbCellera anticipates starting the Phase 1 clinical trial for ABCL635 in Q3 2025 AbCellera (NASDAQ:ABCL) today announced it has received a No Objection Letter (NOL) from Health Canada authorizing its Clinical Trial
AbCellera Reports Q1 2025 Business Results
AbCellera (NASDAQ:ABCL) today announced financial results for the first quarter of 2025. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated. "After completion of a
AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025
Preclinical data on AbCellera's PSMA x CD3 T-cell engagers demonstrate potent anti-tumor activity and potential to further enhance function through costimulatory strategies AbCellera (NASDAQ:ABCL) today announced new
Связанные акции
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.